Breast cancer, Ovarian cancer
Results
Phase 2
This trial was to find out how well a new treatment called rucaparib works. Rucaparib is also known as CO-338, AG-014699, or PF-01367338.
The trial was for people with an inherited fault in the or gene who had locally advanced or advanced breast cancer, or advanced ovarian cancer. Women with high grade serous ovarian cancer who did not have a BRCA gene fault could also take part.
Cancer Research UK supported this trial.
Recruitment start: 14 January 2008
Recruitment end: 22 January 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Ruth Plummer
Cancer Research UK (Centre for Drug Development)
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUKD/08/042.
Last reviewed: 2 May 2016
CRUK internal database number: 730
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
